Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 448  
This article has been cited by
Suresh C. Srivastava,Leonard F. Mausner
2Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review
D. Magalhães,I. L. Sampaio,G. Ferreira,P. Bogalho,D. Martins-Branco,R. Santos,H. Duarte
Journal of Endocrinological Investigation.2019;42(3)249
3Peptide receptor radionuclide therapy of neuroendocrine tumours
Tessa Brabander,Jaap J.M. Teunissen,Casper H.J. Van Eijck,Gaston J.H. Franssen,Richard A. Feelders,Wouter W. de Herder,Dik J. Kwekkeboom
Best Practice & Research Clinical Endocrinology & Metabolism.2016;30(1)103
4Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer?
Fernanda Vaisman,Paulo Henrique Rosado de Castro,Flavia Paiva Proença Lobo Lopes,Daniel Barretto Kendler,Cencita H.N. Pessoa,Daniel Alves Bulzico,Douglas de Carvalho Leal,Bruno Vilhena,Mario Vaisman,Michel Carneiro,Rossana Corbo
Clinical Nuclear Medicine.2015;40(2)123
5Paving the Way to Personalized Medicine: Production of Some Promising Theragnostic Radionuclides at Brookhaven National Laboratory
Suresh C. Srivastava
Seminars in Nuclear Medicine.2012;42(3)151

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal